Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...

California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin Newsom's initial timeline.

Gensaic partnership with Novo Nordisk, worth up to $354M, aims to develop next-generation precision therapies using novel protein design technology.

Novo is paying Gensaic up to $354 million per target in upfront fees and development and commercial milestones, plus tiered ...

AbbVie is jumping into the burgeoning obesity field, striking a license agreement with Gubra that is potentially worth more than $2 billion to the Danish drug-discovery and contract-research-services ...

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...

We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on ValueInvestorsClub by cable888. In this article, we will ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

In the early aughts, Paula Deen was a powerhouse in the food world. Her career over the years has had its share of scandalous ...

Novo Nordisk A/S, BlackRock, Blackstone, Apollo Global Management, and Welltower are the five Growth stocks to watch today, ...

The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and ...

Infinitus is trying to catch the attention of Big Pharma with a billboard-based campaign rolling out in New Jersey, spelling out a future where humans and AI work together.